COMMUNIQUÉS West-GlobeNewswire

Myriad Reschedules Release of Fiscal Fourth-Quarter 2018 Financial Results

13/08/2018 - 13:05

Company Reaffirms Fiscal 2018 Guidance and Will Now Release Results on August 21, 2018 SALT LAKE CITY, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and [...]

Protalix BioTherapeutics Appoints David Granot to its Board of Directors

13/08/2018 - 13:00

CARMIEL, Israel, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American: PLX, TASE: PLX), announced today that the Company’s Board of Directors has appointed Mr. David Granot to serve on the [...]

XORTX Submits FDA pre-IND Meeting Documents

13/08/2018 - 13:00

● Advancing to a Phase II Clinical Study in Polycystic Kidney Disease ● CALGARY, Alberta, Aug. 13, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a [...]

With Excellence in Action Awards, NRC Health recognizes outstanding service and engagement in long-term care and senior living

13/08/2018 - 13:00

Exceptional skilled nursing, assisted living, and independent living organizations earned this national distinction by achieving 90th percentile scores for resident and employee satisfaction LINCOLN, Neb., Aug. 13, 2018 [...]

Urgent need for blood donors before Labour Day

13/08/2018 - 13:00

More than 22,000 donors needed across Canada by August 26 OTTAWA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- With many blood donors away or busy with summer activities, Labour Day weekend will be a particularly challenging time [...]

Urgent besoin de donneurs de sang d’ici la fête du Travail

13/08/2018 - 13:00

Nous avons besoin de plus de 22,000 donneurs à la grandeur du pays d’ici le 26 août. OTTAWA, 13 août 2018 (GLOBE NEWSWIRE) -- La fin de semaine de la fête du Travail représente un défi particulier pour ce qui est du don [...]

RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections

13/08/2018 - 13:00

Once granted, the new patent, which covers both RHB-104 and RHB-204, is expected to be valid until at least 2029 RedHill recently announced positive top-line results from the randomized, double-blind, placebo-controlled [...]

Auxly Announces Strategic Partnership With Cannabis OneFive

13/08/2018 - 13:00

VANCOUVER, British Columbia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that it has entered into a strategic partnership with Cannabis [...]

Tonix Pharmaceuticals Reports Second Quarter 2018 Financial Results and Operational Highlights

13/08/2018 - 13:00

HONOR Study Results to be Included in Poster Presentation at a Scientific Conference in August 2018 FDA Meeting in October 2018 Confirmed to Discuss New Phase 3 Study for Tonmya® in PTSD New Phase 3 Study for Tonmya May [...]

Zealand hosts conference call on August 16 at 4 pm CET/10 am EDT to present first half of 2018 results

13/08/2018 - 12:58

Press Release - No. 18 / 2018 Zealand hosts conference call on August 16 at 4 pm CET/10 am EDT to present first half of 2018 results Copenhagen, August 13, 2018 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) [...]

Stemline Therapeutics Announces that FDA Accepts ELZONRIS™ Biologics License Application (BLA) and Grants Priority Review

13/08/2018 - 12:30

Conference call on BLA acceptance and commercial readiness scheduled for Monday, August 13, 2018 at 8:30 AM ET NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical-stage [...]

Nightstar Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights

13/08/2018 - 12:05

Regenerative Medicine Advanced Therapy (RMAT) Designation received in June 2018 for NSR-REP1 in Choroideremia Preliminary data from Phase 1/2 XIRIUS trial for X-Linked Retinitis Pigmentosa expected at EURETINA 2018 in [...]

Adherium Launches Hailie™ Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management

13/08/2018 - 12:00

SAN MATEO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX: ADR), a leading digital health platform that focuses on improving medication adherence and patient outcomes, today officially launched the Hailie™ [...]

Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results

13/08/2018 - 12:00

Publication of PEDMARK TM SIOPEL 6 Clinical Data in The New England Journal of Medicine Joined Russell 3000 Index Strong financial position with $25.6 million in cash and no debt RESEARCH TRIANGLE PARK, N.C., Aug. 13, [...]

Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain

13/08/2018 - 11:30

Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has been approved for in-store allergy testing [...]

1st Patient Treated for Osteoarthritis Knee Pain in Sorrento Resiniferatoxin Phase 1B Trial Meets Both Safety and Efficacy Expectations

13/08/2018 - 10:00

SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that the first enrolled patient in the phase 1b study of its non-opioid, afferent nerve ablating drug [...]

Immunicum AB (publ) to Present Preclinical Data on Ilixadencel in Combination with CPIs and Immune Enhancers at ESMO 2018 Congress

13/08/2018 - 08:01

Press Release 13 August 2018 Immunicum AB (publ) to Present Preclinical Data on Ilixadencel in Combination with CPIs and Immune Enhancers at ESMO 2018 Congress Immunicum AB (publ; IMMU.ST) announced today that the [...]

New Drug Application Submitted in Japan for INTUNIV® (guanfacine hydrochloride extended release) in Adults with ADHD

13/08/2018 - 08:00

New Drug Application Submitted in Japan for INTUNIV ® (guanfacine hydrochloride extended release) in Adults with ADHD Shire’s partner, Shionogi, filed application to expand INTUNIV ® indication in Japan to include [...]

Basilea reports on first Cresemba® approval in MENA region

13/08/2018 - 07:16

Basel, Switzerland, August 13, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Hikma Pharmaceuticals LLC, gained regulatory approval for the antifungal Cresemba ® (isavuconazole) in Jordan [...]